Novo Nordisk and Vivtex partner to develop oral drugs for obesity and diabetes / Bio-Technopark Schlieren-Zürich / beUnity

Novo Nordisk and Vivtex partner to develop oral drugs for obesity and diabetes

In English
Auf Deutsch

Bio-Technopark Schlieren-Zürich Ufficiale